Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity
Author:
Publisher
John Wiley & Sons, Ltd
Link
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002250.pub2/epdf/full
Reference66 articles.
1. Antimicrobial prophylaxis in pregnancy: a randomized placebo-controlled trial with cefetamet-pivoxil in pregnant women with a poor obstetric history;Gichangi;American Journal of Obstetrics and Gynecology,1997
2. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis;Hauth;New England Journal of Medicine,1995
3. Prospective, double-blinded, randomized, placebo-controlled trial of short-course erythromycin (E) base in women at high risk for preterm birth;McGregor,1988
4. Cervicovaginal microflora and pregnancy outcome: results of a double-blind, placebo-controlled trial of erythromycin treatment;McGregor;American Journal of Obstetrics and Gynecology,1990
5. Erythromycin treatment of pregnant women to reduce the incidence of low birth weight and preterm deliveries;Paul;International Journal of Gynecology & Obstetrics,1998
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Interventions for women with premature cervical dilatation and exposed fetal membranes to prevent pregnancy loss and preterm birth – A systematic review and meta-analysis;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09
2. Maternal inflammatory and microbial drivers of low birthweight in low- and middle-income countries;Paediatrics and International Child Health;2024-04-02
3. Strategies for Safeguarding High-Risk Pregnancies From Preterm Birth: A Narrative Review;Cureus;2024-03-07
4. Cranberry Supplements for Urinary Tract Infection Prophylaxis in Pregnant Women: A Systematic Review of Clinical Trials and Observational Studies on Efficacy, Acceptability, Outcomes Measurement Methods, and Studies’ Feasibility;Cureus;2023-10-09
5. FETOMATERNAL OUTCOME IN PATIENTS WITH THREATENED ABORTION IN A TERTIARY CARE CENTER IN SOUTH KERALA;Asian Journal of Pharmaceutical and Clinical Research;2023-08-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3